Virtus ETF Advisers’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-4,052
| Closed | -$93.8K | – | 490 |
|
|
2023
Q1 | $93.8K | Sell |
4,052
-1,558
| -28% | -$36.1K | 0.05% | 350 |
|
|
2022
Q4 | $147K | Sell |
5,610
-880
| -14% | -$23.1K | 0.08% | 350 |
|
|
2022
Q3 | $128K | Buy |
6,490
+49
| +0.8% | +$966 | 0.05% | 384 |
|
|
2022
Q2 | $113K | Sell |
6,441
-4,095
| -39% | -$71.8K | 0.04% | 401 |
|
|
2022
Q1 | $172K | Sell |
10,536
-622
| -6% | -$10.2K | 0.08% | 211 |
|
|
2021
Q4 | $182K | Sell |
11,158
-1,474
| -12% | -$24K | 0.07% | 244 |
|
|
2021
Q3 | $161K | Sell |
12,632
-667
| -5% | -$8.5K | 0.07% | 325 |
|
|
2021
Q2 | $188K | Buy |
+13,299
| New | +$188K | 0.08% | 373 |
|
|
2018
Q4 | – | Sell |
-12,293
| Closed | -$452K | – | 398 |
|
|
2018
Q3 | $452K | Sell |
12,293
-8,787
| -42% | -$323K | 0.05% | 135 |
|
|
2018
Q2 | $738K | Buy |
21,080
+2,600
| +14% | +$91K | 0.65% | 78 |
|
|
2018
Q1 | $859K | Buy |
18,480
+9,933
| +116% | +$462K | 0.75% | 64 |
|
|
2017
Q4 | $321K | Buy |
8,547
+2,410
| +39% | +$90.5K | 0.4% | 114 |
|
|
2017
Q3 | $327K | Buy |
6,137
+561
| +10% | +$29.9K | 0.04% | 127 |
|
|
2017
Q2 | $318K | Buy |
5,576
+464
| +9% | +$26.5K | 0.05% | 110 |
|
|
2017
Q1 | $275K | Buy |
5,112
+490
| +11% | +$26.4K | 0.05% | 147 |
|
|
2016
Q4 | $263K | Buy |
4,622
+420
| +10% | +$23.9K | 0.08% | 127 |
|
|
2016
Q3 | $261K | Hold |
4,202
| – | – | 0.13% | 120 |
|
|
2016
Q2 | $238K | Buy |
4,202
+2,609
| +164% | +$148K | 0.18% | 106 |
|
|
2016
Q1 | $102K | Buy |
+1,593
| New | +$102K | 0.14% | 143 |
|